Beijing Kawin Technology Share-holding Co Ltd
SSE:688687

Watchlist Manager
Beijing Kawin Technology Share-holding Co Ltd Logo
Beijing Kawin Technology Share-holding Co Ltd
SSE:688687
Watchlist
Price: 22.5 CNY -1.14% Market Closed
Market Cap: 3.8B CNY

Beijing Kawin Technology Share-holding Co Ltd
Operating Income

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Beijing Kawin Technology Share-holding Co Ltd
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Beijing Kawin Technology Share-holding Co Ltd
SSE:688687
Operating Income
¥167.5m
CAGR 3-Years
21%
CAGR 5-Years
21%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Operating Income
-¥4.2B
CAGR 3-Years
23%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Operating Income
¥1.4B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
RemeGen Co Ltd
SSE:688331
Operating Income
-¥1.4B
CAGR 3-Years
N/A
CAGR 5-Years
-29%
CAGR 10-Years
N/A
Akeso Inc
HKEX:9926
Operating Income
-¥675.3m
CAGR 3-Years
19%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
S
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990
Operating Income
-¥212.1m
CAGR 3-Years
36%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Beijing Kawin Technology Share-holding Co Ltd
Glance View

Market Cap
3.8B CNY
Industry
Biotechnology

Beijing Kawin Technology Share-Holding Co., Ltd. provides biotechnology treatment solutions and medicines. The company is headquartered in Beijing, Beijing and currently employs 647 full-time employees. The company went IPO on 2021-02-08. The firm's recombinant human interferon α2b and compound glycyrrhizin drugs are applied to treat viral diseases. The firm mainly distributes its products within domestic market.

Intrinsic Value
21.39 CNY
Overvaluation 5%
Intrinsic Value
Price

See Also

What is Beijing Kawin Technology Share-holding Co Ltd's Operating Income?
Operating Income
167.5m CNY

Based on the financial report for Dec 31, 2024, Beijing Kawin Technology Share-holding Co Ltd's Operating Income amounts to 167.5m CNY.

What is Beijing Kawin Technology Share-holding Co Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
21%

Over the last year, the Operating Income growth was 16%. The average annual Operating Income growth rates for Beijing Kawin Technology Share-holding Co Ltd have been 21% over the past three years , 21% over the past five years .

Back to Top